Donislecel

CHEMBL4594332 Phase 4 Đã phê duyệt Cell
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A cell therapy consisting of transplanted pancreatic islet cells used to restore insulin production in patients with type 1 diabetes. The transplanted cells help control blood sugar levels in patients who experience severe hypoglycemia despite optimal medical management.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A cell therapy consisting of transplanted pancreatic islet cells used to restore insulin production in patients with type 1 diabetes. The transplanted cells help control blood sugar levels in patients who experience severe hypoglycemia despite optimal medical management.

Yes, Donislecel is an approved drug. It has reached clinical phase 4. It is classified as a Cell.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594332. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.